Clinical and Lung Function Outcomes After Anti-IgE or Anti-IL5 Therapy in Severe Asthma

Clinical and Lung Function Outcomes After Anti-IgE or Anti-IL5 Therapy in Severe Asthma

Saad AlShareef,1 Christine F McDonald,2– 4 Joy Lee2,5 1Department of Medicine, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, 13317-4233, Saudi Arabia; 2Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, Australia; 3Institute for Breathing and S...

Full description

Bibliographic Details
Main Authors: AlShareef S, McDonald CF, Lee J
Format: Article
Language:English
Published: Dove Medical Press 2022-02-01
Series:Journal of Asthma and Allergy
Subjects:
asthma
benralizumab
exacerbations
omalizumab
mepolizumab
monoclonal antibody
Online Access:https://www.dovepress.com/clinical-and-lung-function-outcomes-after-anti-ige-or-anti-il5-therapy-peer-reviewed-fulltext-article-JAA

Internet

https://www.dovepress.com/clinical-and-lung-function-outcomes-after-anti-ige-or-anti-il5-therapy-peer-reviewed-fulltext-article-JAA

Similar Items